ProMIS Neurosciences, Inc. Stock price Toronto S.E.
Equities
PMN
CA74346M4065
Biotechnology & Medical Research
Sales 2023 * | - | Sales 2024 * | - | Capitalization | 48.86M 35.99M |
---|---|---|---|---|---|
Net income 2023 * | -17M -12.52M | Net income 2024 * | -28M -20.63M | EV / Sales 2023 * | - |
Net cash position 2023 * | - 0 | Net cash position 2024 * | - 0 | EV / Sales 2024 * | - |
P/E ratio 2023 * |
-1.78
x | P/E ratio 2024 * |
-1.87
x | Employees | 7 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 76.77% |
Managers | Title | Age | Since |
---|---|---|---|
Neil Warma
CEO | Chief Executive Officer | 61 | 21-05-12 |
Neil Cashman
FOU | Founder | 72 | 04-01-22 |
Eugene Williams
CHM | Chairman | 64 | 15-06-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
William W. Wyman
BRD | Director/Board Member | 86 | 14-03-07 |
Neil Cashman
FOU | Founder | 72 | 04-01-22 |
Neil Warma
CEO | Chief Executive Officer | 61 | 21-05-12 |
1st Jan change | Capi. | |
---|---|---|
+1.10% | 106B | |
+9.29% | 103B | |
-2.47% | 21.44B | |
-11.89% | 22.11B | |
-26.59% | 20.99B | |
-5.01% | 19.44B | |
-6.58% | 17.6B | |
+5.83% | 13.88B | |
+7.46% | 11.75B |